Solis, Baby Girl .

HRN: 28-79-87  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2026
AMPICILLIN 250MG (VIAL)
04/10/2026
04/17/2026
IV
140 Mg
Q12
NAMF (Chorioamnionitis); Possibly Septic Newborn
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: